| Immune checkpoint inhibitors in the treatment of HCC C Donisi, M Puzzoni, P Ziranu, E Lai, S Mariani, G Saba, V Impera, ... Frontiers in oncology 10, 601240, 2021 | 105 | 2021 |
| New therapeutic targets in pancreatic cancer E Lai, M Puzzoni, P Ziranu, A Pretta, V Impera, S Mariani, N Liscia, P Soro, ... Cancer treatment reviews 81, 101926, 2019 | 92 | 2019 |
| Gastric cancer: translating novels concepts into clinical practice M Salati, G Orsi, E Smyth, G Beretta, F De Vita, M Di Bartolomeo, ... Cancer treatment reviews 79, 101889, 2019 | 67 | 2019 |
| A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the ‘BRAF BeCool’study F Loupakis, R Intini, C Cremolini, A Orlandi, A Sartore-Bianchi, ... European Journal of Cancer 118, 121-130, 2019 | 66 | 2019 |
| Clustered protocadherins methylation alterations in cancer AF Vega-Benedetti, E Loi, L Moi, S Blois, A Fadda, M Antonelli, A Arcella, ... Clinical epigenetics 11, 1-20, 2019 | 48 | 2019 |
| BRCA-mutant pancreatic ductal adenocarcinoma E Lai, P Ziranu, D Spanu, M Dubois, A Pretta, S Tolu, S Camera, N Liscia, ... British Journal of Cancer 125 (10), 1321-1332, 2021 | 42 | 2021 |
| Introducing immunotherapy for advanced hepatocellular carcinoma patients: Too early or too fast? E Lai, G Astara, P Ziranu, A Pretta, M Migliari, M Dubois, C Donisi, ... Critical Reviews in Oncology/hematology 157, 103167, 2021 | 35 | 2021 |
| Molecular-biology-driven treatment for metastatic colorectal cancer E Lai, N Liscia, C Donisi, S Mariani, S Tolu, A Pretta, M Persano, G Pinna, ... Cancers 12 (5), 1214, 2020 | 30 | 2020 |
| Colorectal cancer early detection in stool samples tracing CpG islands methylation alterations affecting gene expression AF Vega-Benedetti, E Loi, L Moi, S Orrù, P Ziranu, A Pretta, E Lai, ... International Journal of Molecular Sciences 21 (12), 4494, 2020 | 29 | 2020 |
| The role of primary tumour sidedness, EGFR gene copy number and EGFR promoter methylation in RAS/BRAF wild-type colorectal cancer patients receiving irinotecan/cetuximab L Demurtas, M Puzzoni, R Giampieri, P Ziranu, V Pusceddu, A Mandolesi, ... British Journal of Cancer 117 (3), 315-321, 2017 | 26 | 2017 |
| Fluropyrimidine single agent or doublet chemotherapy as second line treatment in advanced biliary tract cancer C Neuzillet, A Casadei‐Gardini, B Brieau, C Vivaldi, G Brandi, ... International Journal of Cancer 147 (11), 3177-3188, 2020 | 25 | 2020 |
| BRAF-mutant colorectal cancer, a different breed evolving E Lai, A Pretta, V Impera, S Mariani, R Giampieri, L Casula, V Pusceddu, ... Expert Review of Molecular Diagnostics 18 (6), 499-512, 2018 | 25 | 2018 |
| Thyroid hormones ratio is a major prognostic marker in advanced metastatic colorectal cancer: Results from the phase III randomised CORRECT trial G Pasqualetti, M Schirripa, E Dochy, M Fassan, P Ziranu, M Puzzoni, ... European Journal of Cancer 133, 66-73, 2020 | 23 | 2020 |
| Angiogenesis genotyping and clinical outcomes in patients with advanced hepatocellular carcinoma receiving sorafenib: the ALICE-2 study L Faloppi, M Puzzoni, A Casadei Gardini, N Silvestris, G Masi, G Marisi, ... Targeted Oncology 15, 115-126, 2020 | 19 | 2020 |
| The role of immune checkpoint inhibitors in the treatment sequence of advanced gastric or gastro-esophageal junction cancer: A systematic review and meta-analysis of randomized … M Dubois, N Liscia, O Brunetti, P Ziranu, E Lai, A Argentiero, E Mazza, ... Critical Reviews in Oncology/Hematology 173, 103674, 2022 | 17 | 2022 |
| HOXD8 hypermethylation as a fully sensitive and specific biomarker for biliary tract cancer detectable in tissue and bile samples E Loi, C Zavattari, A Tommasi, L Moi, M Canale, A Po, C Sabato, ... British Journal of Cancer 126 (12), 1783-1794, 2022 | 16 | 2022 |
| Prognostic value of thyroid hormone ratios in patients with advanced metastatic colorectal cancer treated with regorafenib: the TOREADOR study M Schirripa, G Pasqualetti, R Giampieri, M Scartozzi, S Lonardi, ... Clinical colorectal cancer 17 (3), e601-e615, 2018 | 16 | 2018 |
| Retrospective Comparative Analysis of KRAS G12C vs. Other KRAS Mutations in mCRC Patients Treated With First-Line Chemotherapy Doublet + Bevacizumab R Giampieri, A Lupi, P Ziranu, A Bittoni, A Pretta, F Pecci, M Persano, ... Frontiers in Oncology 11, 736104, 2021 | 12 | 2021 |
| New Horizons in Metastatic Colorectal Cancer: Prognostic Role of CD44 Expression P Ziranu, V Aimola, A Pretta, M Dubois, R Murru, N Liscia, F Cau, ... Cancers 15 (4), 1212, 2023 | 11 | 2023 |
| Why precision medicine should be applied across the continuum of care for metastatic colorectal cancer patients M Puzzoni, P Ziranu, L Demurtas, E Lai, S Mariani, N Liscia, P Soro, ... Future Oncology 16 (02), 4337-4339, 2020 | 11 | 2020 |
